InnovAge Holding
INNV
9.13
+0.13
+1.44%
InnovAge Holding
US · INNV
#3115 by market cap
Listed 2021
9.13
+0.13
+1.44%
Live - 5344 symbols - heartbeat 294s ago
· 2026-10-08 04:03
Pre-market
9.14
+0.11%
After-hours
9.13
0.00%
- Market cap
- 1.25B
- P/E (TTM)i
- -456.50
- P/Bi
- 5.29
- EPSi
- -0.02
- Div yieldi
- 0.00%
- 52W posi
- 60%
Reader sentiment
Are you bullish or bearish on INNV?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 4.16, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +15.93% YoY
Margins
- Gross margin
- 23.01%
- Operating margin
- 0.58%
- Net margin
- -0.26%
Key ratios & quality
- Enterprise valuei
- 1.16B
- Altman Z-Scorei
- 4.16
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 465.63M | 567.19M | 637.80M | 698.64M | 688.09M | 763.86M | 853.70M | 989.71M |
| Gross profit | 110.63M | 141.30M | 174.08M | 135.37M | 101.29M | 132.06M | 153.64M | 227.76M |
| Selling & admin expenses | 64.71M | 77.48M | 154.57M | 125.85M | 135.26M | 136.29M | 150.28M | 200.85M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 39.68M | 51.61M | -10.99M | -4.41M | -49.40M | -23.18M | -16.15M | 5.77M |
| Pretax profit | 25.39M | 35.63M | -34.97M | -7.24M | -50.79M | -21.82M | -34.03M | 266.00K |
| Tax | 6.32M | 9.87M | 9.77M | 723.00K | -7.24M | 1.40M | 1.32M | 949.00K |
| Net profit | 19.07M | 25.77M | -44.74M | -7.96M | -43.55M | -23.22M | -35.34M | -683.00K |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.13 | 0.19 | -0.36 | -0.05 | -0.30 | -0.16 | -0.22 | -0.02 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 218.14M | 221.42M | 236.11M | 239.71M | 251.94M | 261.95M |
| Gross profit | 40.75M | 41.29M | 51.36M | 52.83M | 61.02M | 62.56M |
| Selling & admin expenses | 45.52M | 34.92M | 37.88M | 34.69M | 85.28M | 43.01M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | -10.16M | 2.97M | 8.39M | 13.26M | -29.08M | 13.20M |
| Pretax profit | -11.06M | -4.20M | 7.92M | 12.46M | -29.77M | 9.67M |
| Tax | 72.00K | 807.00K | 247.00K | 651.00K | 167.00K | -116.00K |
| Net profit | -11.13M | -5.01M | 7.67M | 11.81M | -29.94M | 9.78M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.08 | -0.01 | 0.06 | 0.08 | -0.22 | 0.06 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 119.45M | 166.93M | 250.93M | 240.96M | 215.23M | 173.14M | 176.11M | 214.31M |
| Cash & ST investments | 59.66M | 112.90M | 201.47M | 184.43M | 173.46M | 102.78M | 105.90M | 141.33M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 363.23M | 409.63M | 531.75M | 555.60M | 567.36M | 547.66M | 526.85M | 557.39M |
| Total current liabilities | 83.46M | 76.63M | 78.57M | 105.31M | 148.45M | 138.60M | 164.81M | 203.89M |
| Short-term debt | 3.63M | 3.43M | 5.87M | 7.16M | 12.05M | 12.54M | 12.17M | 13.40M |
| Long-term debt | 186.82M | 210.43M | 71.57M | 68.21M | 64.84M | 61.48M | 57.46M | 45.52M |
| Total liabilities | 281,792,000.00 | 301,884,000.00 | 173,787,000.00 | 201,852,000.00 | 252,558,000.00 | 247,853,000.00 | 263,943,000.00 | 288,617,000.00 |
| Total equity | 81.44M | 107.75M | 357.97M | 353.74M | 314.80M | 299.81M | 262.91M | 268.78M |
| Retained earnings | 38.46M | 64.74M | 10.66M | 4.73M | -35.94M | -68.31M | -101.05M | -105.76M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 176.18M | 176.11M | 161.70M | 181.85M | 202.61M | 214.31M |
| Cash & ST investments | 101.73M | 105.90M | 109.42M | 125.96M | 138.59M | 141.33M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 536.65M | 526.85M | 510.23M | 527.48M | 547.39M | 557.39M |
| Total current liabilities | 225.32M | 164.81M | 138.49M | 144.70M | 195.89M | 203.89M |
| Short-term debt | 71.14M | 12.17M | 12.80M | 12.32M | 12.34M | 13.40M |
| Long-term debt | 1.77M | 57.46M | 56.15M | 55.99M | 55.43M | 45.52M |
| Total liabilities | 268,943,000.00 | 263,943,000.00 | 234,468,000.00 | 238,719,000.00 | 288,500,000.00 | 288,617,000.00 |
| Total equity | 267.71M | 262.91M | 275.77M | 288.76M | 258.89M | 268.78M |
| Retained earnings | -97.84M | -101.05M | -93.03M | -82.41M | -111.87M | -105.76M |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 25.91M | 43.83M | -7.55M | 27.30M | 20.24M | -36.90M | 32.87M | 64.71M |
| Depreciation & amortization | 9.00M | 11.29M | 12.29M | 13.92M | 15.42M | 18.95M | 19.51M | 21.14M |
| Free cash flow | 11.42M | 31.98M | -27.09M | -10.94M | -3.12M | -44.81M | 26.60M | 50.41M |
| Dividends paid | -66.51M | 0 | -9.50M | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 277.00K | 0 | 292.87M | -- | 0 | -179.00K | -7.32M | 0 |
| Ending cash balance | 61.20M | 114.57M | 203.70M | 184.45M | 127.27M | 56.96M | 64.14M | 97.90M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 24.63M | 9.00M | 3.92M | 21.36M | 18.14M | 21.29M |
| Depreciation & amortization | 5.39M | 3.39M | 5.09M | 4.88M | 4.82M | 6.36M |
| Free cash flow | 21.73M | 9.18M | -153.00K | 19.00M | 14.54M | 17.02M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -1.11M | -297.00K | 0 | 0 | 0 | 0 |
| Ending cash balance | 60.47M | 64.14M | 67.16M | 83.21M | 95.55M | 97.90M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 26.39 | 30.00 | -20.17 | -1.95 | -12.94 | -7.55 | -12.02 | -1.08 |
| ROA %i | 5.39 | 6.80 | -9.34 | -1.20 | -7.24 | -3.83 | -5.64 | -0.47 |
| ROIC %i | 9.95 | 12.52 | -8.61 | -1.11 | -9.58 | -4.66 | -7.48 | 0.01 |
| 5-year avg ROE %i | -- | -- | -- | -- | 4.26 | -2.53 | -10.93 | -7.11 |
| EBIT margin %i | 7.51 | 8.86 | -2.85 | -0.67 | -7.16 | -2.33 | -3.45 | 0.46 |
| FCF / sales %i | 2.45 | 5.64 | -- | -- | -- | -- | 3.12 | 5.09 |
| Current ratioi | 1.43 | 2.18 | 3.19 | 2.29 | 1.45 | 1.25 | 1.07 | 1.05 |
| Quick ratioi | 1.37 | 2.10 | 3.05 | 2.16 | 1.33 | 1.11 | 0.88 | 0.92 |
| Debt / assetsi | 53.62 | 53.21 | 15.54 | 15.26 | 19.18 | 20.64 | 19.19 | 15.60 |
| LT debt / equityi | 257.63 | 212.37 | 22.94 | 23.36 | 32.67 | 37.32 | 37.84 | 31.22 |
| Interest coveragei | 3.65 | 3.44 | -1.08 | -1.87 | -32.37 | -4.42 | -6.38 | 1.06 |
| Revenue CAGR (3Y) %i | -- | -- | -- | 14.48 | 6.65 | 6.20 | 6.91 | 12.88 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -12.03 | -12.02 | -6.86 | 2.56 | -4.97 | -1.08 |
| ROA %i | -5.87 | -5.64 | -3.35 | 1.23 | -2.14 | -0.47 |
| ROIC %i | -7.45 | -7.48 | -3.90 | 2.88 | -2.70 | 0.01 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -3.08 | -3.45 | -1.83 | 1.18 | -0.97 | 0.46 |
| FCF / sales %i | 1.92 | 3.12 | 4.09 | 5.44 | 4.48 | 5.09 |
| Current ratioi | 0.78 | 1.07 | 1.17 | 1.26 | 1.03 | 1.05 |
| Quick ratioi | 0.66 | 0.88 | 0.98 | 1.04 | 0.87 | 0.92 |
| Debt / assetsi | 19.64 | 19.19 | 19.22 | 18.08 | 17.14 | 15.60 |
| LT debt / equityi | 14.39 | 37.84 | 34.81 | 32.34 | 35.59 | 31.22 |
| Interest coveragei | -5.01 | -6.38 | -3.50 | 1.90 | -2.11 | 1.06 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Program of All-Inclusive Care for the Elderly (PACE) is the largest reported line at 99.97% of revenue, across 2 reported segments.
- The next-largest line, All other, is a distant second at 0.03% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Program of All-Inclusive Care for the Elderly (PACE)99.97%
Region
United States100.00%
Quote time 2026-10-08 04:03:49 · For reference only, not investment advice and not tailored to your situation.